IL-1β favors the progression of MASLD, allowing lipid accumulation in hepatocytes and increasing inflammation by the rise of neutrophil recruitment through the expression of intracellular adhesion molecule (ICAM-1) (97). The gene discussed is IL1B; the disease is metabolic dysfunction-associated steatotic liver disease.